Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Fitzgerald

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
British Journal of Clinical Pharmacology|April 1, 1976
Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drugF J Conway, J D Fitzgerald, J McAinsh, et al.
Clinical Pharmacology and Therapeutics|June 1, 1977
Oral and intravenous propranolol during exerciseJ R Sutton, R L Hughson, R McDonald, et al.
Lupus|October 2, 2008
Some antiphospholipid antibodies bind to hemostasis and fibrinolysis proteases and promote thrombosisP P Chen, C D Yang, K Ede, et al.
Chest|April 1, 1978
Aerosol therapy with Sch 1000. Short-term mucociliary clearance in normal and bronchitic subjects and toxicology in normal subjectsR E Ruffin, R K Wolff, M B Dolovich, et al.
Lancet (London, England)|November 30, 1985
Intravenous epidermal growth factor/urogastrone increases small-intestinal cell proliferation in congenital microvillous atrophyJ A Walker-Smith, A D Phillips, N Walford, et al.
Archives of Internal Medicine|January 13, 1997
Functional status among survivors of in-hospital cardiopulmonary resuscitation. SUPPORT Investigators Study to Understand Progress and Preferences for Outcomes and Risks of TreatmentJ D FitzGerald, N S Wenger, R M Califf, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
British Journal of Clinical Pharmacology|April 1, 1976
Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drugF J Conway, J D Fitzgerald, J McAinsh, et al.
Clinical Pharmacology and Therapeutics|June 1, 1977
Oral and intravenous propranolol during exerciseJ R Sutton, R L Hughson, R McDonald, et al.
Lupus|October 2, 2008
Some antiphospholipid antibodies bind to hemostasis and fibrinolysis proteases and promote thrombosisP P Chen, C D Yang, K Ede, et al.
Chest|April 1, 1978
Aerosol therapy with Sch 1000. Short-term mucociliary clearance in normal and bronchitic subjects and toxicology in normal subjectsR E Ruffin, R K Wolff, M B Dolovich, et al.
Lancet (London, England)|November 30, 1985
Intravenous epidermal growth factor/urogastrone increases small-intestinal cell proliferation in congenital microvillous atrophyJ A Walker-Smith, A D Phillips, N Walford, et al.
Archives of Internal Medicine|January 13, 1997
Functional status among survivors of in-hospital cardiopulmonary resuscitation. SUPPORT Investigators Study to Understand Progress and Preferences for Outcomes and Risks of TreatmentJ D FitzGerald, N S Wenger, R M Califf, et al.
Pageof 5